These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21282321)

  • 1. Intrathecal baclofen in multiple sclerosis: too little, too late?
    Erwin A; Gudesblatt M; Bethoux F; Bennett SE; Koelbel S; Plunkett R; Sadiq S; Stevenson VL; Thomas AM; Tornatore C; Zaffaroni M; Hughes M
    Mult Scler; 2011 May; 17(5):623-9. PubMed ID: 21282321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome and complications of intrathecal baclofen pump in multiple sclerosis patients: a retrospective study.
    Khan AA; Birks-Agnew I; Bullock P; Rushton D
    NeuroRehabilitation; 2010; 27(2):117-20. PubMed ID: 20871140
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction.
    Nelson MES; McGuire JR
    Neuromodulation; 2019 Oct; 22(7):839-842. PubMed ID: 31157471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
    Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
    Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
    Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New treatment for spasticity--intrathecal baclofen therapy].
    Nemoto A; Sakata K
    Nihon Rinsho; 2008 Apr; 66(4):789-99. PubMed ID: 18409533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal baclofen therapy: ten steps toward best practice.
    Ridley B; Rawlins PK
    J Neurosci Nurs; 2006 Apr; 38(2):72-82. PubMed ID: 16681287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcome of intrathecal baclofen administration for severe spasticity.
    Boviatsis EJ; Kouyialis AT; Korfias S; Sakas DE
    Clin Neurol Neurosurg; 2005 Jun; 107(4):289-95. PubMed ID: 15885386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
    Sampson FC; Hayward A; Evans G; Morton R; Collett B
    J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intrathecal baclofen infusions. An introduction and overview.
    Kamensek J
    Axone; 1999 Mar; 20(3):67-72. PubMed ID: 10401268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief.
    McClelland S; Bethoux FA; Boulis NM; Sutliff MH; Stough DK; Schwetz KM; Gogol DM; Harrison M; Pioro EP
    Muscle Nerve; 2008 Mar; 37(3):396-8. PubMed ID: 17894358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrathecal baclofen therapy and management of severe spasticity].
    Naito Y
    Brain Nerve; 2014 Sep; 66(9):1049-55. PubMed ID: 25200576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and management of tolerance in intrathecal baclofen therapy.
    Heetla HW; Staal MJ; Kliphuis C; van Laar T
    Spinal Cord; 2009 Oct; 47(10):751-6. PubMed ID: 19333246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.
    Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS;
    Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing spasticity with intrathecal drug delivery.
    Barker E
    RN; 2008 Apr; 71(4):24-9; quiz 30. PubMed ID: 18524352
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
    de Lissovoy G; Matza LS; Green H; Werner M; Edgar T
    J Child Neurol; 2007 Jan; 22(1):49-59. PubMed ID: 17608306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.